Clinical trial
Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
NCT00005837 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005837 |
|---|---|
| Title | Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer |
| Official title | Phase II Evaluation of Oxaliplatin in Persistent or Recurrent Squamous Cell Carcinoma of the Cervix |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Start date | Feb 1, 2000 |
| Completion | Jun 1, 2004 |
| First posted | May 5, 2003 |
| Last update posted | Jun 21, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: